Secure your session
We are opening our calendar on April 7 for personalized walkthroughs. Reserve your spot now to see how MRD Express integrates with your workflow.
Unrivaled speed
24 hour personalized panel turnaround from order to shipment enables earlier detection of circulating tumor DNA, supporting more sensitive characterization of residual disease at the molecular level.
Enterprise scale
Power your most ambitious diagnostic programs with the ability to produce thousands of personalized panels per day, touchless automated ordering, and ISO-grade manufacturing quality.
Ultra-sensitive detection
Unlike amplicon-based methods, target-enriched MRD testing tracks a broad range of patient-specific tumor variants simultaneously, delivering ultra-sensitive detection of residual disease even at extremely low levels.
No more compromise between speed and sensitivity
Tumor-informed detection is the gold standard for MRD assay developers. However, maximizing performance has historically required selecting between amplicon and hybrid capture-based technologies, forcing a frustrating choice between turnaround time and sensitivity.
Now, you don’t have to choose. MRD Express cuts 7-day production timelines to provide tumor-informed, hybrid capture panels in 24 hours from design submission to shipment, all while maintaining best-in-class sensitivity.
Note: Performance values represent typical industry ranges for personalized MRD workflows. Turnaround Time is measured from design submission to panel shipment. Limit of Detection (LoD95) is based on parts per million (ppm). Hybrid capture typically tracks 500–2000+ variants to achieve 0.5–5 ppm sensitivity, whereas amplicon-based methods generally track 16–64 variants with a 10–200 ppm LoD.
Schedule your walkthrough
Twist Bioscience HQ
681 Gateway Blvd
South San Francisco, CA 94080
